Endoscope Market Report: Trends, Forecast and Competitive Analysis to 2035

Endoscope Market

The future of the global endoscope market looks promising with opportunities in the hospital & clinic and physical examination center markets. The global endoscope market is expected to reach an estimated $33.7 billion by 2035 from $20.9 billion in 2027 with a CAGR of 3.6% from 2027 to 2035. The major drivers for this market are the increasing demand for minimally invasive surgeries, the rising incidence of digestive disorders, and the growing adoption of disposable endoscopes.

• Lucintel forecasts that, within the type category, disposable endoscopes is expected to witness the highest growth over the forecast period due to increased infection risk and elimination of reprocessing costs.
• Within the application category, hospital & clinic is expected to witness higher growth over the forecast period due to increased demand for minimally invasive diagnostic procedures.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to increasing in the scope of hospital equipment in the region.

Emerging Trends in Endoscope Market

The endoscope market during the years 2025-2027 will transition from purchase of equipment to purchase of visualization platforms along with procedure specific services and continuing services. Hospitals and ambulatory surgery centers are focused on purchasing equipment that provides early diagnosis with lower trauma. Lucintel's report is based upon FDA clearances, company filing, and gastroenterology investments.

• Artificial Intelligence: AI has the ability to detect polyps and recognize the anatomy. In January 2025, the FDA cleared more than 1,000 endoscopy software AI devices. AI will change purchasing because of the time and diagnostic precision of the procedure.
• Outpatient Migration: In 2025, the U.S. Ambulatory Surgery Centers captured more gastrointestinal procedures. Payers are choosing lower cost sites, and hospital capacity is an issue. Demand for portable systems over the next 3 to 5 years will be high due to fast room turnover and compact towers.
• Single-use Adoption: Boston Scientific and other suppliers promoted single use devices in 2025. Marketing single use devices meets the concern of infection and the cost of reprocessing. The relative high cost of the devices will be offset by the improved economics of utilization.
• Visualization Integration: In their 2025 report, Olympus stated that endoscopy is a major recurring technology. Several suppliers added 4K imaging, narrow-band visualization, and cloud connected systems. Integration of systems will change competition from productivity of systems to workflow and upgrade of systems.
• Specialty Expansion: Manufacturers continued their development of endoscopic solutions for bariatric therapy, cholangioscopy, and advanced tissue sampling in 2025, moving beyond diagnostic procedures. Therapeutic applications will improve the relative value of procedures and motivate hospitals to replace general equipment with specialty configurations.

In the next three years, suppliers will be in greater demand who provide clinical evidence with reliable systems, compatible accessories, and flexible reimbursement. Capital budgets are still conservative, but the increasing number of procedures continues to support targeted replacements. Soon, the focus of competition within the industry will move beyond image quality and more into the software, the economics of service, and the ideal fit of the workflow. Manufacturers who successfully reduce the burden of training and the cost of reprocessing will reliably capture new market share in hospitals and outpatient facilities worldwide.

Recent Developments in the Endoscope Market

The future of the market is moving from sale of large, capital endoscopes, to sale of connected, modular, procedure-specific endoscopy platforms. High volume demand and activity is expected through 2025 to 2027 while hospitals replace their reusable systems, outpatient centers expand, and regulatory bodies approve the use of artificial intelligence (AI). Lucintel expects ongoing market growth with the competitive advantage shifting to visualization, infection control, and even more affordable total procedure costs.

• AI Assistance: With the January 2025 FDA clearance of Medtronic's GI Genius for expanded detection of colorectal polyps, market demand for software-enabled endoscopy will grow. Endoscopy equipment vendors are expected to offer hardware, along with service contracts and bundled algorithms and supporting clinical evidence in the next 5 years.
• Single-use: Organic revenue growth by 21% in the first fiscal quarter of fiscal 2025 (January 2025) for Ambu is attributed to single-use endoscopy. Vendors of single-use endoscopes for bronchoscopy and critical care endoscopies are favored by hospitals due to the removal of the need for reprocessing.
• Visualization: In April 2025, Fujifilm released ELUXEO 8000 in Japan to improve visualization and simplify the workflow. Premium visual systems will drive market replacements, especially in gastrointestinal endoscopy, where the performance of visual systems directly impacts buying decisions.
• Outpatient Expansion: Boston Scientific's purchase of Axonics for approximately $3.7 billion in July 2025, builds the company's urology and pelvic health platform. This purchase is not an endoscopy deal, but it is another example of acquisitions focused on the overall surgical ecosystem and represents Boston Scientific's continued investment in the ambulatory care space and its associated tech.
• Service-led Contracting: Olympus announced approximately ¥997 billion in sales for its fiscal year ending March 2025, emphasizing the importance of recurring revenue and lifecycle services. This will totally disrupt the procurement process for hospitals and medical centers. Rather than purchasing individual services or products on a one-off basis, hospitals will want to purchase bundled offerings that include service level agreements (SLAs) for uptime, updates for security and other safety features, and predictable total cost of ownership (TCO).

Looking ahead, the market will value quality of Revenues and not just the volume of services sold, especially in the next 3 to 5 years. This will include disposables, outpatient migration, and replacement demand. Suppliers with best-in-class solutions and service networks will grow market share, and pricing on standard flexible endoscopes will remain highly competitive as purchasing remains centralized in many hospitals.

Strategic Growth Opportunities in the Endoscope Market

During the next few years, alterations in endoscope market demand due to procedure backlogs, aging and migratory populations, and the movement from inpatient to outpatient care, will reshape endoscope market demand for suppliers. Efficient use of hospital capital will lead to greater emphasis on the efficiency of reusable devices and measurable outcomes, while the use of AI will expand the clinical use of endoscopes. Lucintel's market perspective will be useful in identifying revenue streams beyond core endoscopes.

• Ambulatory Procedure Platforms: The creation of more compact systems will allow for the capture of procedures in office-based gastroenterology and bronchoscopy. HCA Healthcare reported 2,200 ambulatory sites in February 2025, increasing the potential customer base. In the next 3-5 years the demand will be for flexible, low-cost systems that can be quickly implemented.
• AI-Assisted Diagnosis: The use of software to detect polyps, bleeding, and lesions will create a recurring source of revenue. In January 2025, the FDA listed more than 1,000 authorized AI-enabled medical devices, and showed that the path for clinical use is increasing. The quality of detection will be a key factor in purchasing, as providers will tie the quality of detection to reimbursement and the productivity of the endoscope.
• Single Use Endoscopes: Single use systems will be driven by the infection control and reprocessing challenges that exist with bronchoscopy, urology, and critical care. In March 2025, Ambu reported more than 2 million cumulative bronchoscopies with its single use systems. The growth of the procedure will create continuous revenue streams from consumables.
• Advanced Therapeutic Visualization: Surgical endoscopes that incorporate advanced imaging and endoscopic surgical tools will allow companies to charge a premium in oncology and complex cases involving the gastrointestinal system. In April 2025, Olympus reported a 10.5% increase in its endoscopy solutions segment for the previous fiscal year. With increasingly complex procedures, competition will switch from optical excellence to clinical excellence.
• Emerging Market Service Networks: Endoscopy can be a profitable enterprise, provided services include local repairs and training along with reprocessing, beyond major urban hospitals. In June 2025, the Global Health Workforce Alliance estimated a shortage of 11 million health workers by 2030. In countries with low levels of health worker availability, adoption will depend on the service networks of endoscopy equipment distributors.

There is a shift in the endoscopy market from selling equipment to offering endoscopy-related services based on recurring disposables and data. Clinical superiority will drive market expansion alongside simplicity in reprocessing and shifting hospital budgets. The ability to move AI products through regulatory systems will be of great importance during this period. Volume in the next five years should come from new markets offering ambulatory services, while maintaining profit margins through advanced visualization.

Endoscope Market Drivers and Challenges

The endoscope market is shaped by technological progress, rising diagnostic demand, healthcare investment, economic conditions, and evolving regulation. Minimally invasive procedures are expanding as providers seek faster recovery and lower hospitalization costs. Artificial intelligence, flexible imaging, and robotic assistance are improving clinical performance, while sustainability and reprocessing requirements influence purchasing decisions. Lucintel identifies demographic aging, chronic disease prevalence, and infrastructure expansion as important long-term influences. However, high equipment costs, infection-control risks, reimbursement pressure, and shortages of trained specialists may limit adoption, particularly in developing healthcare systems and smaller facilities.

The factors responsible for driving this market include:

• Advanced Imaging and Artificial Intelligence: High-definition, three-dimensional, narrow-band, fluorescence, and artificial-intelligence-assisted imaging are improving lesion detection and diagnostic confidence. In January 2025, clinical systems continued progressing toward real-time computer-aided polyp detection, supporting wider use of AI during colonoscopy. Over the next three to five years, automated visualization, documentation, and risk assessment should increase procedure efficiency and encourage hospitals to upgrade legacy equipment.
• Rising Minimally Invasive Procedures: Patients and physicians increasingly prefer endoscopic interventions because they generally require smaller incisions, shorter hospital stays, and faster recovery than open surgery. In 2025, global healthcare systems continued expanding outpatient and ambulatory endoscopy services, with procedures increasingly moving outside traditional hospitals. This shift will support market growth over the next three to five years as aging populations and chronic gastrointestinal, respiratory, and urological diseases raise procedure volumes.
• Aging Population and Disease Burden: Growing numbers of older adults are increasing demand for screening, diagnosis, surveillance, and therapeutic endoscopy. In 2025, people aged 65 years and above represented more than 10% of the global population, strengthening demand for gastrointestinal, pulmonary, and urological examinations. During the next three to five years, higher cancer incidence, obesity, reflux disease, and colorectal disorders will sustain recurring demand for endoscopes and related accessories.
• Infrastructure Investment and Healthcare Access: Public and private investment in hospitals, ambulatory surgery centers, and diagnostic clinics is improving access to endoscopic services in emerging markets. In 2025, healthcare infrastructure programs in several Asian and Middle Eastern economies continued adding advanced imaging and surgical capacity. Over the next three to five years, expanded facilities, insurance coverage, and localized training will enable more procedures, supporting demand for both premium and cost-effective endoscopy systems.
• Product Innovation and Manufacturing Efficiency: Manufacturers are developing thinner scopes, improved ergonomics, disposable components, enhanced sterilization designs, and connected operating-room platforms. In 2025, single-use endoscope development remained a major innovation area, particularly for bronchoscopy and selected urology applications. Over the next three to five years, improved manufacturing, modular designs, and lower maintenance requirements will broaden adoption, while competition may reduce ownership costs and increase product availability.

The challenges facing this market include:

• High Acquisition and Operating Costs: Advanced endoscopy towers, robotic platforms, processors, imaging systems, and specialized accessories require substantial capital investment. In 2025, a complete premium endoscopy suite could require several hundred thousand dollars before installation, training, and service costs. Over the next three to five years, budget constraints and unequal reimbursement will slow adoption among smaller hospitals, limiting market penetration despite strong clinical demand.
• Infection Control and Reprocessing Risks: Reusable endoscopes contain narrow channels that require rigorous cleaning, disinfection, drying, inspection, and traceability. In 2025, facilities continued investing in automated endoscope reprocessors and monitoring systems because inadequate processing can create serious infection risks. Over the next three to five years, stricter protocols, liability concerns, and demand for single-use devices will raise operating expenses and complicate purchasing decisions.
• Regulatory, Reimbursement, and Workforce Constraints: Endoscope manufacturers face extensive validation, cybersecurity, safety, and quality requirements across international markets. The European Union's Medical Device Regulation includes transition deadlines extending to December 31, 2027, for certain devices, increasing compliance planning. Over the next three to five years, complex approvals, uncertain reimbursement, and shortages of skilled endoscopists and technicians may delay installations and restrict utilization in underserved regions.

The endoscope market will expand as minimally invasive care, aging populations, chronic disease, advanced imaging, and healthcare infrastructure investment increase procedure volumes. Artificial intelligence, connected systems, disposable technologies, and manufacturing improvements will strengthen clinical value and operational efficiency. Nevertheless, high capital requirements, reprocessing risks, complex regulation, reimbursement limitations, and workforce shortages will create uneven adoption. Market participants that provide affordable, interoperable, easy-to-clean, and clinically validated systems will be best positioned for growth. Overall, technological innovation will drive long-term opportunity, while cost control, training, safety, and regulatory execution will determine how broadly these benefits reach healthcare providers worldwide.

List of Endoscope Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies endoscope market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the endoscope market companies profiled in this report include-

• Olympus
• KARL STORZ
• Stryker
• Richard Wolf
• Fujifilm
• HOYA
• Medtronic
• Ankon
• SonoScape
• Jinshan

Endoscope Market by Segment

The study includes a forecast for the global endoscope market by type, product, application, and region.

Endoscope Market by Type [Value ($B) from 2019 to 2035]:

• Rigid Endoscopes
• Flexible Endoscopes
• Disposable Endoscopes

Endoscope Market by Product [Value ($B) from 2019 to 2035]:

• Gastrointestinal Endoscopy
• Respiratory / Bronchoscopy
• Urology Endoscopy
• Gynecology & Reproductive Endoscopy
• ENT Endoscopy
• Others

Endoscope Market by Application [Value ($B) from 2019 to 2035]:

• Hospital & Clinic
• Physical Examination Center
• Others

Endoscope Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Endoscope Market

The market for endoscopes is changing with the addition of regulatory hurdles, reusable endoscope market demand, advanced AI technologies for visual aids, and rapid investment by hospitals. As indicated in the latest report by Lucintel, equipment replacement together with technology upgrades is expected to increase in the next few years.

• United States: Medtronic's GI Genius system provided continued support for computer-aided colorectal polyp detection, and Boston Scientific's $3.7 billion acquisition of Axonics in February 2025 completed its minimally invasive portfolio. It is anticipated that the combined visualization, therapeutic devices and software will result in accelerated replacement of capital equipment over the next 3 to 5 years in both the outpatient and hospital based settings.
• China: The National Health Commission of China published its 2025 plan for the expansion of colorectal cancer screening and early diagnosis, and continued development of high definition and disposable endoscopes by local manufacturers occurred. This is expected to increase use and reinforce demand for locally produced systems under centralized purchasing.
• Germany: As hospitals in Germany continued to invest funds allocated by the €11.5 billion Hospital Future Fund, KARL STORZ continued to make integrated digital technologies and reusable visualization systems. The fund is driving modernization of hospitals which is creating demand for advanced endoscopy and connected surgical technologies.
• India: The Indian government's Production-Linked Incentive (PLI) scheme for medical devices, worth around ₹3,420 crore, continued in 2025 and both local companies and multinational suppliers continued to build local assembly and distribution capacity. This is significant because, through localization, the cost of equipment can go down and the scope of service can be expanded to include small hospitals located in rural areas.
• Japan: For the next ten years, Olympus will invest in endoscopy, and in the meantime, is continuing to sell the EVIS X1 System with the highest imaging functions. * High definition, AI-based endoscopy systems will continue to be preferred by the Japanese clinically-based community and there will be a sustained demand for replacement in the face of an aging population.

Features of the Global Endoscope Market

• Market Size Estimates: endoscope market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: endoscope market size by type, product, application, and region in terms of value ($B).
• Regional Analysis: endoscope market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, products, applications, and regions for the endoscope market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the endoscope market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the endoscope market by type (rigid endoscopes, flexible endoscopes, and disposable endoscopes), product (gastrointestinal endoscopy, respiratory / bronchoscopy, urology endoscopy, gynecology & reproductive endoscopy, ENT endoscopy, and others), application (hospital & clinic, physical examination center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?